Numbers first: SURMOUNT-2 · nausea · 10 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Unanswered questions
Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Concretely: aspartimide formation · tirzepatide · 4 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
Setup, so nobody has to ask: a Karl Fischer water content test · a two-person split. The failure mode I am trying to avoid is making this decision emotionally. I have…
What I am working with: a 25G drawing needle · a GLP-1 receptor agonist · 10 mg/mL. Both of these get recommended confidently by different people, which suggests…
The case in front of me: semaglutide · twelve weeks · 4 °C. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow…
The specifics, since they change the answer: liraglutide · 40 °C. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has…
Stated plainly: orforglipron · phosphate-buffered diluent. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am…
Details up front: retatrutide · two weeks. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the…
Setup, so nobody has to ask: a mini-fridge · orforglipron. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is…
Conditions: 98.8% · a C4 column · dulaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
What I have: a GLP-1 receptor agonist · sixteen weeks · 4 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can…
Conditions: PeptideMeter · 97.6%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
Concretely: a low-dead-space syringe · 2 mg · 6.67 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the…
Setup, so nobody has to ask: nausea · orforglipron · ATTAIN-1. I have read the primary source rather than the summary, which has left me with more questions. I…
Concretely: SURMOUNT-3 · vomiting · 10 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The particulars: 98.4% · ecnoglutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
Concretely: reflux · seven · cagrilintide. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a problem…
The specifics, since they change the answer: 98.4% · chromatogram. I want to understand what this actually establishes, as opposed to what it is being used to imply.…
The vial was lyophilised at the time, which I understand may matter a great deal. I would like to set this up properly once, rather than adjust it repeatedly. My…
The case in front of me: Wuhan · Australia. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The case in front of me: HbA1c · liraglutide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically,…
The specifics, since they change the answer: oral semaglutide · three weeks · 30 °C. I understand the observation; what I do not understand is the mechanism behind…
The case in front of me: reflux · orforglipron. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
What I am working with: potassium · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit…